Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Luebeck – page 18

359 clinical trials in Luebeck, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Luebeck at a glance
359
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

359 trials in Luebeck

Open in trial search

Dermatitis atopic

Not recruiting

Study on Rezpegaldesleukin for Treating Moderate-to-Severe Atopic Dermatitis in Adults

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Rezpegaldesleukin
  • Sponsor:Nektar Therapeutics

Asthmatic crisis

Not recruiting

Study on the Effects of Verekitug (UPB-101) for Adults with Severe Asthma

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Human Igg1 Kappa Monoclonal Antibody Against Crlf2
  • Sponsor:Upstream Bio Inc.

Psoriasis

Not recruiting

Study on the Effects of JNJ-81241459 for Patients with Moderate to Severe Psoriasis

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Jnj-81241459
  • Sponsor:Janssen Cilag International

Study on the Effects of Semaglutide in Patients with Non-Alcoholic Steatohepatitis (NASH) and Fibrosis Stages 2 or 3

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

Study on the Effectiveness of NNC0194-0499 and Semaglutide in Treating Non-Alcoholic Steatohepatitis (NASH) in Patients with Fibrosis Stages 2-4

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Asthma

Not recruiting

Study on the Effects of Atuliflapon in Adults with Moderate to Severe Uncontrolled Asthma

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atuliflapon
  • Sponsor:AstraZeneca AB

Asthma

Not recruiting

Study on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:Chiesi Farmaceutici S.p.A.

Dermatitis atopic

Not recruiting

Study on Long-Term Safety and Efficacy of Amlitelimab for Patients with Moderate to Severe Atopic Dermatitis from Previous Trials

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Amlitelimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study on the Effectiveness and Safety of Deucravacitinib for Patients with Active Systemic Lupus Erythematosus (SLE)

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Study on Trilaciclib and Topotecan for Patients with Extensive Stage Small Cell Lung Cancer

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Glucose Monohydrate
  • Sponsor:Pharmacosmos A/S

Study of Astegolimab Treatment in Patients with Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Astegolimab
  • Sponsor:F. Hoffmann-La Roche AG

Hidradenitis

Not recruiting

A study to evaluate the effectiveness and safety of BFB759 in adults with moderate to severe hidradenitis suppurativa

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Bluefin Biomedicine Inc.

Other cities in Germany

The busiest research cities in the country

All 516 cities in Germany

Clinical research in Luebeck

What the registry says about research in the country

01 Oncology Research

Advanced clinical trials focusing on various cancer types, including metastatic prostate cancer, breast cancer, and non-small cell lung cancer. Studies evaluate novel therapeutic approaches and combination treatments.

  • Breast Cancer Treatments
  • Prostate Cancer Therapies
  • Lung Cancer Innovations

Investigating groundbreaking treatments targeting specific genetic markers and exploring immunotherapy combinations.

02 Neurological Disorders

Innovative research addressing acute cerebral ischemic stroke and amyotrophic lateral sclerosis (ALS). Studies focus on improving patient outcomes and testing new therapeutic agents.

  • Stroke Treatment
  • ALS Management
  • Neurological Recovery

Evaluating novel compounds to enhance neurological function and patient quality of life.

03 Autoimmune Conditions

Research into VEXAS syndrome and systemic autoimmune rheumatic diseases. Studies examine innovative treatments for complex inflammatory conditions.

  • Rheumatic Disease Management
  • Inflammatory Disorders
  • Lung Disease Complications

Testing new therapeutic approaches for rare and challenging autoimmune conditions.

04 Dermatological Studies

Clinical trials investigating treatments for hidradenitis suppurativa and atopic dermatitis. Research focuses on innovative therapies for chronic skin conditions.

  • Chronic Skin Conditions
  • Inflammatory Skin Disorders
  • Novel Treatment Approaches

Evaluating new therapeutic options for improving patient outcomes in persistent skin conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.